Orthofix Medical (OFIX) Amortization of Deferred Charges (2018 - 2026)
Orthofix Medical has reported Amortization of Deferred Charges over the past 14 years, most recently at $1.1 million for Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges fell 15.43% year-over-year to $1.1 million, compared with a TTM value of $5.7 million through Mar 2026, down 63.37%, and an annual FY2025 reading of $5.9 million, down 62.68% over the prior year.
- Amortization of Deferred Charges came in at $1.1 million for Q1 2026, down from $2.0 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $11.3 million in Q4 2024 to a low of $735000.0 in Q4 2022.
- Median Amortization of Deferred Charges over the past 5 years was $1.5 million (2024), compared with a mean of $2.0 million.
- The sharpest move saw Amortization of Deferred Charges skyrocketed 307.07% in 2023, then plummeted 82.52% in 2025.
- Over 5 years, Amortization of Deferred Charges stood at $735000.0 in 2022, then skyrocketed by 307.07% to $3.0 million in 2023, then soared by 277.67% to $11.3 million in 2024, then plummeted by 82.52% to $2.0 million in 2025, then crashed by 46.43% to $1.1 million in 2026.
- Per Business Quant, the three most recent readings for OFIX's Amortization of Deferred Charges are $1.1 million (Q1 2026), $2.0 million (Q4 2025), and $1.6 million (Q3 2025).